Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Flamen

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
EJNMMI Physics|December 14, 2020
Combined quality and dose-volume histograms for assessing the predictive value of <sup>99m</sup>Tc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancerHugo Levillain, Manuela Burghelea, Ivan Duran Derijckere, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2004
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic valueKoen Van Laere, Sarah Ceyssens, Frank Van Calenbergh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2002
Preservation of parotid function with uncomplicated conformal radiotherapyAnnelies Maes, Caroline Weltens, Patrick Flamen, et al.
EJNMMI Physics|June 2, 2026
Quantitative accuracy of <sup>177</sup>Lu SPECT/CT imaging using ring-shaped CZT versus dual-head NaI systemsRachele Danieli, Clémentine Marin, Anna-Lena Theisen, et al.
Oncology Reports|July 6, 2006
Clinical added-value of 18FDG PET in neuroendocrine-merkel cell carcinomaTarik Belhocine, Gerald E Pierard, Janos Frühling, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 30, 2021
Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal CancerErwin Woff, Lisa Salvatore, Federica Marmorino, et al.
Anticancer Research|February 10, 2017
Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic ResponseGabriel Liberale, Céline Lecocq, Camilo Garcia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 28, 2023
PSMA PET/CT for Response Assessment and Overall Survival Prediction in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway InhibitorsQaid Ahmed Shagera, Ioannis Karfis, Paulus Kristanto, et al.
Oncotarget|September 17, 2017
N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by <sup>89</sup>Zr-Trastuzumab and <sup>18</sup>F-FDG PET imagingZéna Wimana, Geraldine Gebhart, Thomas Guiot, et al.
Clinical Nuclear Medicine|June 29, 2023
Tumor Volume on PSMA PET as a Prognostic Biomarker in Prostate Cancer Patients Treated With CabazitaxelQaid Ahmed Shagera, Ioannis Karfis, Spyridon Sideris, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
EJNMMI Physics|December 14, 2020
Combined quality and dose-volume histograms for assessing the predictive value of <sup>99m</sup>Tc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancerHugo Levillain, Manuela Burghelea, Ivan Duran Derijckere, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2004
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic valueKoen Van Laere, Sarah Ceyssens, Frank Van Calenbergh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2002
Preservation of parotid function with uncomplicated conformal radiotherapyAnnelies Maes, Caroline Weltens, Patrick Flamen, et al.
EJNMMI Physics|June 2, 2026
Quantitative accuracy of <sup>177</sup>Lu SPECT/CT imaging using ring-shaped CZT versus dual-head NaI systemsRachele Danieli, Clémentine Marin, Anna-Lena Theisen, et al.
Oncology Reports|July 6, 2006
Clinical added-value of 18FDG PET in neuroendocrine-merkel cell carcinomaTarik Belhocine, Gerald E Pierard, Janos Frühling, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 30, 2021
Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal CancerErwin Woff, Lisa Salvatore, Federica Marmorino, et al.
Anticancer Research|February 10, 2017
Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic ResponseGabriel Liberale, Céline Lecocq, Camilo Garcia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 28, 2023
PSMA PET/CT for Response Assessment and Overall Survival Prediction in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway InhibitorsQaid Ahmed Shagera, Ioannis Karfis, Paulus Kristanto, et al.
Oncotarget|September 17, 2017
N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by <sup>89</sup>Zr-Trastuzumab and <sup>18</sup>F-FDG PET imagingZéna Wimana, Geraldine Gebhart, Thomas Guiot, et al.
Clinical Nuclear Medicine|June 29, 2023
Tumor Volume on PSMA PET as a Prognostic Biomarker in Prostate Cancer Patients Treated With CabazitaxelQaid Ahmed Shagera, Ioannis Karfis, Spyridon Sideris, et al.
Pageof 13